about
Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitorsDescending control of nociception: Specificity, recruitment and plasticitySpinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medullaNeonatal local noxious insult affects gene expression in the spinal dorsal horn of adult ratsOpioid receptor heteromers in analgesiaStress enhances muscle nociceptor activity in the ratAltered formalin-induced pain and Fos induction in the periaqueductal grey of preadolescent rats following neonatal LPS exposureEmotional modulation of pain and spinal nociception in fibromyalgia.Brainstem control of cerebral blood flow and application to acute vasospasm following experimental subarachnoid hemorrhage.Differential endogenous pain modulation in complex-regional pain syndrome.A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain.Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia.Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: a potential circuit mediating the sexually dimorphic actions of morphine.Microinjection of IL-1β into the trigeminal transition zone produces bilateral NMDA receptor-dependent orofacial hyperalgesia involving descending circuitry.Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis techniqueNeuropeptide Y in the rostral ventromedial medulla reverses inflammatory and nerve injury hyperalgesia in rats via non-selective excitation of local neurons.WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression.Unmasking the mysteries of the habenula in pain and analgesia.Pains, gains, and midbrains.Levels of neuropeptide Y in synovial fluid relate to pain in patients with knee osteoarthritis.Noxious counterirritation in patients with advanced osteoarthritis of the knee reduces MCC but not SII pain generators: A combined use of MEG and EEG.Algogenic substances and metabolic status in work-related Trapezius Myalgia: a multivariate explorative study.A preconditioning nerve lesion inhibits mechanical pain hypersensitivity following subsequent neuropathic injury.Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferentsAbnormal endogenous pain modulation is a shared characteristic of many chronic pain conditionsActivation of rostral ventromedial medulla neurons by noxious stimulation of cutaneous and deep craniofacial tissues.Descending pain modulation and chronification of pain.Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.Orexin-a modulates firing of rat rostral ventromedial medulla neurons: an in vitro studyA role of supraspinal galanin in behavioural hyperalgesia in the rat.Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome.Involvement and role of the hypothalamo-pituitary-adrenal (HPA) stress axis in animal models of chronic pain and inflammation.Effect of Exercise on µ-Opioid Receptor Expression in the Rostral Ventromedial Medulla in Neuropathic Pain Rat Model.Mechanical Antiallodynic Effect of Intrathecal Nefopam in a Rat Neuropathic Pain Model.Mapping pain activation and connectivity of the human habenulaPsychophysical and cerebral responses to heat stimulation in patients with central pain, painless central sensory loss, and in healthy persons.Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer.Chronic temporomandibular disorders are not necessarily associated with a compromised endogenous analgesic system.
P2860
Q21203940-29DC612A-D422-4F77-B431-164D90325F80Q24624664-52B9CDF2-6266-4865-B0D9-FFCEDF7D6639Q24624781-FC2FD22B-D47A-48E8-B389-EA8FC37568AFQ24814493-03BE7EF4-A4B3-4560-A512-373BF9E74C47Q27004306-0D40AAF5-D137-497E-934E-F3A9DFD56E52Q28388747-5E60AA3A-E98F-4B6B-A94A-D9D24CB1DCB4Q28539200-3B3C597A-E3AF-4513-B6B5-A79B8EB13C67Q30435830-CEF29C59-99D7-420E-AFBA-3CA5D7D2FAE3Q30490018-BB4B6DD1-3B11-46A1-89A5-09CB3AE79379Q33400940-34BBCB5C-87AC-46C0-94D7-C19FD07ECC49Q33578684-8D668B10-AB80-44FF-9B64-99CCB265C805Q33618276-3F23128C-3ECA-42A8-B7BD-A54E446ED3BBQ33642749-50DDCEFB-B5E1-4287-9D49-889A69493C23Q33661832-5527075B-9D51-4C54-AE4D-0FF8564CDCDCQ33714148-9574705B-C466-4313-A165-7FF0F1CBD632Q33774088-9A197B4B-6060-4C92-8BE4-A4BA4328A153Q33807425-87CF6F76-A0A7-4C77-A26A-D410F0009340Q34112969-CAA73A80-67B5-4587-879D-2896FD1D5D1EQ34136359-FBDEFC36-ADD8-4975-8D39-529D1A169D6AQ34212776-624FA711-BE0E-41D8-882C-A4B54DA52332Q34333206-F0B457F2-467C-45A0-82D5-90FF0C2FB711Q34418165-A5226BB7-5E26-4E66-9D11-9A6B364989A6Q34470172-12CF3E8E-B5EA-4A07-881F-84EEDD78417CQ34499429-04919C3B-7C43-40AF-9764-DF88C9CA9A41Q34515420-A6BBC9E0-BE72-4D9E-B583-A7C7951C30DEQ34637931-ADB591DB-6373-47D5-8B8B-7E9E3AD7A208Q34959427-A47473AB-2D05-43D4-ADBA-76C2EA06F533Q34993456-301BF1EF-BECB-4A33-9D2B-941260313A09Q35009932-88C0EA55-6854-4843-A3A8-E3B88D83E2E6Q35080568-ED2147B3-2EEC-4C65-9D44-A5EF36A16470Q35369442-0E2A58C1-0F17-4588-8388-429F1E20A0A7Q35432010-6A1D6F72-8527-444F-8678-8DDC0972E426Q35596877-4B6310BD-7EE0-4668-BE40-4FF230788DD6Q35809322-B6C92A9E-7D3C-4B71-A867-D35280938854Q35833501-81987F70-5D07-4B6F-A3F9-F67C5C7231A5Q35905164-23635047-52EC-4CBD-BA09-A39BEB0FEC7BQ35994881-4ADF7D92-02DD-4712-8877-19393C5F9240Q36123096-719754BA-4B4D-488E-ADEA-4B1E1888A212Q36178615-162A7650-DC5F-4340-88AD-9F3D5475FC00Q36233118-63FA6B53-AF82-4502-B656-94F803FB0694
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Descending modulation in persistent pain: an update.
@ast
Descending modulation in persistent pain: an update.
@en
Descending modulation in persistent pain: an update.
@nl
type
label
Descending modulation in persistent pain: an update.
@ast
Descending modulation in persistent pain: an update.
@en
Descending modulation in persistent pain: an update.
@nl
prefLabel
Descending modulation in persistent pain: an update.
@ast
Descending modulation in persistent pain: an update.
@en
Descending modulation in persistent pain: an update.
@nl
P1433
P1476
Descending modulation in persistent pain: an update.
@en
P2093
P356
10.1016/S0304-3959(02)00368-8
P407
P577
2002-11-01T00:00:00Z